Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases

Hepatobiliary and Pancreatic Diseases International

Volumn 13, Issue 6, 2014, Pages 570-579

  Kurzepa, Jacek ^a   M, Agnieszka ^a   Czechowska, Grazyna ^a   Kurzepa, Joanna ^b   Celiński, Krzysztof ^a   Kazmierak, Weronika ^a   Slstrokomka, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b University Hospital No 4   (Poland)

Author keywords

chronic pancreatitis; liver fibrosis; matrix metalloproteinase; non specific inflammatory bowel diseases

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

CHRONIC PANCREATITIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY BOWEL DISEASE; LIVER FIBROSIS; NONHUMAN; PATHOGENESIS; REVIEW; LIVER CIRRHOSIS; METABOLISM;

HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; PANCREATITIS, CHRONIC; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84930275034     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(14)60261-7     Document Type: Review

References (85)

1. M Groblewska, B Mroczko, M Szmitkowski The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development Postepy Hig Med Dosw (Online) 64 2010 22 30
2. D Lipka, J Boratyński Metalloproteinases. Structure and function Postepy Hig Med Dosw (Online) 62 2008 328 336
3. H Nagase, R Visse, G Murphy Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 2006 562 573
4. J Gross, CM Lapiere Collagenolytic activity in amphibian tissues: a tissue culture assay Proc Natl Acad Sci U S A 48 1962 1014 1022
5. P Fic, I Zakrocka, J Kurzepa, A Stepulak Matrix metalloproteinases and atherosclerosis Postepy Hig Med Dosw (Online) 65 2011 16 27
6. H Cha, E Kopetzki, R Huber, M Lanzendörfer, H Brandstetter Structural basis of the adaptive molecular recognition by MMP9 J Mol Biol 320 2002 1065 1079
7. S Rowsell, P Hawtin, CA Minshull, H Jepson, SM Brockbank, DG Barratt et al. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor J Mol Biol 319 2002 173 181
8. SM Wilhelm, IE Collier, BL Marmer, AZ Eisen, GA Grant, GI Goldberg SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages J Biol Chem 264 1989 17213 17221
9. G Murphy, V Knäuper Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol 15 1997 511 518
10. G Opdenakker, PE Van den Steen, J Van Damme Gelatinase B: a tuner and amplifier of immune functions Trends Immunol 22 2001 571 579
11. M Polette, B Nawrocki-Raby, C Gilles, C Clavel, P Birembaut Tumour invasion and matrix metalloproteinases Crit Rev Oncol Hematol 49 2004 179 186
12. Y Yu, T Koike, S Kitajima, E Liu, M Morimoto, M Shiomi et al. Temporal and quantitative analysis of expression of metalloproteinases (MMPs) and their endogenous inhibitors in atherosclerotic lesions Histol Histopathol 23 2008 1503 1516
13. JD Mott, Z Werb Regulation of matrix biology by matrix metalloproteinases Curr Opin Cell Biol 16 2004 558 564
14. S Chandler, R Coates, A Gearing, J Lury, G Wells, E Bone Matrix metalloproteinases degrade myelin basic protein Neurosci Lett 201 1995 223 226
15. FJ Descamps, PE Van den Steen, E Martens, F Ballaux, K Geboes, G Opdenakker Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin FASEB J 17 2003 887 889
16. L Herszényi, G Lakatos, I Hritz, MZ Varga, G Cierny, Z Tulassay The role of inflammation and proteinases in tumor progression Dig Dis 30 2012 249 254
17. L Herszényi, I Hritz, G Lakatos, MZ Varga, Z Tulassay The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer Int J Mol Sci 13 2012 13240 13263
18. M Durlik, K Gardian Metalloproteinase 2 and 9 activity in the development of pancreatic cancer Pol Przegl Chir 84 2012 377 382
19. R Schmidt, A Bültmann, M Ungerer, N Joghetaei, O Bülbül, S Thieme et al. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction Circulation 113 2006 834 841
20. D Leppert, RL Lindberg, L Kappos, SL Leib Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis Brain Res Brain Res Rev 36 2001 249 257
21. H Ito, M Duxbury, E Benoit, TE Clancy, MJ Zinner, SW Ashley et al. Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2 Cancer Res 64 2004 7439 7446
22. G Doronzo, I Russo, L Mattiello, M Trovati, G Anfossi C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells J Lab Clin Med 146 2005 287 298
23. MA Petty, JG Wettstein Elements of cerebral microvascular ischaemia Brain Res Brain Res Rev 36 2001 23 34
24. M Loy, D Burggraf, KH Martens, M Liebetrau, N Wunderlich, G Bültemeier et al. A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia J Neurosci Methods 116 2002 125 133
25. QX Sang, H Birkedal-Hansen, HE Van Wart Proteolytic and non-proteolytic activation of human neutrophil progelatinase B Biochim Biophys Acta 1251 1995 99 108
26. G Galazka, LJ Windsor, H Birkedal-Hansen, JA Engler APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide Biochemistry 35 1996 11221 11227
27. K Brew, D Dinakarpandian, H Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
28. N Isnard, JM Legeais, G Renard, L Robert Effect of hyaluronan on MMP expression and activation Cell Biol Int 25 2001 735 739
29. ML Cuzner, D Gveric, C Strand, AJ Loughlin, L Paemen, G Opdenakker et al. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution J Neuropathol Exp Neurol 55 1996 1194 1204
30. GJ Peppin, SJ Weiss Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils Proc Natl Acad Sci U S A 83 1986 4322 4326
31. PE Van den Steen, G Opdenakker, MR Wormald, RA Dwek, PM Rudd Matrix remodelling enzymes, the protease cascade and glycosylation Biochim Biophys Acta 1528 2001 61 73
32. H Sato, T Takino, Y Okada, J Cao, A Shinagawa, E Yamamoto et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 1994 61 65
33. JL Seltzer, AY Lee, KT Akers, B Sudbeck, EA Southon, EA Wayner et al. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction Exp Cell Res 213 1994 365 374
34. AJ Docherty, A Lyons, BJ Smith, EM Wright, PE Stephens, TJ Harris et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity Nature 318 1985 66 69
35. WG Stetler-Stevenson, N Bersch, DW Golde Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity FEBS Lett 296 1992 231 234
36. L Guedez, WG Stetler-Stevenson, L Wolff, J Wang, P Fukushima, A Mansoor et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1 J Clin Invest 102 1998 2002 2010
37. Y Iimuro, T Nishio, T Morimoto, T Nitta, B Stefanovic, SK Choi et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat Gastroenterology 124 2003 445 458
38. T Knittel, M Mehde, A Grundmann, B Saile, JG Scharf, G Ramadori Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat Histochem Cell Biol 113 2000 443 453
39. RC Benyon, MJ Arthur Extracellular matrix degradation and the role of hepatic stellate cells Semin Liver Dis 21 2001 373 384
40. TH Kim, WM Mars, DB Stolz, BE Petersen, GK Michalopoulos Extracellular matrix remodeling at the early stages of liver regeneration in the rat Hepatology 26 1997 896 904
41. X Zhou, CJ Hovell, S Pawley, MI Hutchings, MJ Arthur, JP Iredale et al. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis Liver Int 24 2004 492 501
42. H Herbst, O Heinrichs, D Schuppan, S Milani, H Stein Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver Virchows Arch B Cell Pathol Incl Mol Pathol 60 1991 295 300
43. YJ Chang, JW Liu, PC Lin, LY Sun, CW Peng, GH Luo et al. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis Life Sci 85 2009 517 525
44. YP Han, C Yan, L Zhou, L Qin, H Tsukamoto A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix J Biol Chem 282 2007 12928 12939
45. E Rossi, LA Adams, M Bulsara, GP Jeffrey Assessing liver fibrosis with serum marker models Clin Biochem Rev 28 2007 3 10
46. V Leroy, F Monier, S Bottari, C Trocme, N Sturm, MN Hilleret et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid Am J Gastroenterol 99 2004 271 279
47. M Consolo, A Amoroso, DA Spandidos, MC Mazzarino Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review) Int J Mol Med 24 2009 143 152
48. R Lichtinghagen, O Huegel, T Seifert, CI Haberkorn, D Michels, P Flemming et al. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C Clin Chem 46 2000 183 192
49. P Bedossa, T Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
50. C Trocme, V Leroy, N Sturm, MN Hilleret, S Bottari, F Morel et al. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin J Viral Hepat 13 2006 643 651
51. K Ishak, A Baptista, L Bianchi, F Callea, J De Groote, F Gudat et al. Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
52. I El-Gindy, AT El Rahman, MA El-Alim, SS Zaki Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease Egypt J Immunol 10 2003 27 35
53. MZ da Costa, DR Guarita, SK Ono-Nita, DC Paranaguá-Vezozzo, GE Felga, MR Pedroso et al. Genetic risk for alcoholic chronic pancreatitis Int J Environ Res Public Health 8 2011 2747 2757
54. VA Akhmedov, AV Budylgin, VT Dolgikh The matrix metalloproteinase 9 (MMP-9) and TIMP-1 activities in patients with chronic and recurrent pancreatitis Eksp Klin Gastroenterol 6 2010 11 13
55. P Chen, Y Yuan, S Wang, L Zhan, J Xu Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis Tohoku J Exp Med 208 2006 261 266
56. T Yamaguchi, Y Kihara, M Taguchi, Y Nagashio, M Tashiro, H Nakamura et al. Persistent destruction of the basement membrane of the pancreatic duct contributes to progressive acinar atrophy in rats with experimentally induced pancreatitis Pancreas 31 2005 365 372
57. EK Ng, BL Barent, GS Smith, RJ Joehl, KM Murayama Decreased type IV collagenase activity in experimental pancreatic fibrosis J Surg Res 96 2001 6 9
58. CW Michalski, A Gorbachevski, M Erkan, C Reiser, S Deucker, F Bergmann et al. Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis J Transl Med 5 2007 63
59. KS Manjari, A Jyothy, A Vidyasagar, B Prabhakar, P Nallari, A Venkateshwari Matrix metalloproteinase-9, transforming growth factor-ß1, and tumor necrosis factor-α plasma levels in chronic pancreatitis Indian J Gastroenterol 32 2013 103 107
60. H Yasui, A Andoh, S Bamba, O Inatomi, H Ishida, Y Fujiyama Role of fibroblast growth factor-2 in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human intestinal myofibroblasts Digestion 69 2004 34 44
61. FE Castaneda, B Walia, M Vijay-Kumar, NR Patel, S Roser, VL Kolachala et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP Gastroenterology 129 2005 1991 2008
62. E Esposito, E Mazzon, L Riccardi, R Caminiti, R Meli, S Cuzzocrea Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis J Pineal Res 45 2008 166 173
63. B von Lampe, B Barthel, SE Coupland, EO Riecken, S Rosewicz Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease Gut 47 2000 63 73
64. CK Li, SL Pender, KM Pickard, V Chance, JA Holloway, A Huett et al. Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice J Immunol 173 2004 5171 5179
65. A Wiercinska-Drapalo, J Jaroszewicz, R Flisiak, D Prokopowicz Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity World J Gastroenterol 9 2003 2843 2845
66. G Lakatos, I Hritz, MZ Varga, M Juhász, P Miheller, G Cierny et al. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases Dig Dis 30 2012 289 295
67. G Lakatos, F Sipos, P Miheller, I Hritz, MZ Varga, M Juhász et al. The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis Pathol Oncol Res 18 2012 85 91
68. Y Naito, T Yoshikawa Role of matrix metalloproteinases in inflammatory bowel disease Mol Aspects Med 26 2005 379 390
69. P Garg, M Vijay-Kumar, L Wang, AT Gewirtz, D Merlin, SV Sitaraman Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis Am J Physiol Gastrointest Liver Physiol 296 2009 G175 G184
70. G D'Haens, WJ Sandborn, BG Feagan, K Geboes, SB Hanauer, EJ Irvine et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis Gastroenterology 132 2007 763 786
71. M Martinesi, C Treves, AG Bonanomi, M Milla, S Bagnoli, U Zuegel et al. Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases Clin Immunol 136 2010 51 60
72. MJ Meijer, MA Mieremet-Ooms, W van Duijn, AM van der Zon, R Hanemaaijer, JH Verheijen et al. Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease Inflamm Bowel Dis 13 2007 200 210
73. A Di Sabatino, SL Pender, CL Jackson, JD Prothero, JN Gordon, L Picariello et al. Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies Gastroenterology 133 2007 137 149
74. DM Hayden, C Forsyth, A Keshavarzian The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states J Surg Res 168 2011 315 324
75. M Puthenedam, F Wu, A Shetye, A Michaels, KJ Rhee, JH Kwon Matrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cells Inflamm Bowel Dis 17 2011 260 267
76. Q Gao, MJ Meijer, FJ Kubben, CF Sier, L Kruidenier, W van Duijn et al. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases Dig Liver Dis 37 2005 584 592
77. E Mylona, A Kapranou, J Mavrommatis, S Markaki, A Keramopoulos, L Nakopoulou The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer APMIS 113 2005 246 255
78. U Impola, L Jeskanen, L Ravanti, S Syrjänen, B Baldursson, VM Kähäri et al. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds Br J Dermatol 152 2005 720 726
79. AR Morgan, DY Han, WJ Lam, CM Triggs, AG Fraser, M Barclay et al. Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitis Hum Immunol 72 2011 1117 1127
80. M Vaalamo, ML Karjalainen-Lindsberg, P Puolakkainen, J Kere, U Saarialho-Kere Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations Am J Pathol 152 1998 1005 1014
81. TK Motawi, SM Rizk, AH Shehata Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease J Physiol Biochem 68 2012 529 539
82. C Medina, MW Radomski Role of matrix metalloproteinases in intestinal inflammation J Pharmacol Exp Ther 318 2006 933 938
83. L Mäkitalo, KL Kolho, R Karikoski, H Anthoni, U Saarialho-Kere Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease Scand J Gastroenterol 45 2010 862 871
84. M Kveiborg, J Jacobsen, MH Lee, H Nagase, UM Wewer, G Murphy Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2) Biochem J 430 2010 79 86
85. K Kobayashi, Y Arimura, A Goto, S Okahara, T Endo, Y Shinomura et al. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium J Pathol 209 2006 376 383